Literature DB >> 7612517

The effect of cryopreservation in prevention of ovarian hyperstimulation syndrome.

A Tiitinen1, L M Husa, M Tulppala, N Simberg, M Seppälä.   

Abstract

OBJECTIVE: To evaluate the effect of elective cryopreservation of all embryos in the prevention of severe ovarian hyperstimulation syndrome in women at increased risk, following superovulation for in vitro fertilisation.
DESIGN: Three hundred and ninety women undergoing superovulation for in vitro fertilisation between September 1991 and December 1992.
SETTING: University Infertility Clinic, Helsinki, Finland.
INTERVENTIONS: Twenty-three women were considered to have an increased risk of developing ovarian hyperstimulation syndrome. They were characterised by more than 20 retrieved oocytes and/or by serum oestradiol levels exceeding 10,000 pmol/l on the day of administration of human chorionic gonadotrophin. Instead of cancelling the cycle the oocytes were harvested and fertilised, and all good quality embryos were cryopreserved. The embryos were thawed and replaced during subsequent natural cycles. MAIN OUTCOME MEASURES: Occurrence of ovarian hyperstimulation syndrome and pregnancy rate.
RESULTS: One out of the 23 patients at increased risk developed a moderate degree ovarian hyperstimulation syndrome, while the others had only mild symptoms. Two of the remaining 367 women with no risk developed ovarian hyperstimulation syndrome, both during early pregnancy. Among the 23 patients at increased risk there have been 15 clinical pregnancies after transfer of two to three frozen-thawed embryos in natural cycles, with a 32.6% pregnancy rate.
CONCLUSIONS: Withholding embryo replacement and elective cryopreservation of the embryos is effective in preventing severe ovarian hyperstimulation syndrome. After subsequent replacement in natural cycles the implantation rate per embryo is good (22.7%).

Entities:  

Mesh:

Year:  1995        PMID: 7612517     DOI: 10.1111/j.1471-0528.1995.tb09140.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  5 in total

1.  Pronuclear embryo cryopreservation experience: outcomes for reducing the risk of ovarian hyperstimulation syndrome and for fertility preservation in cancer patients.

Authors:  Mary E Sabatini; Ann M Wolkovich; Eric A Macklin; Diane L Wright; Irene Souter; Thomas L Toth
Journal:  J Assist Reprod Genet       Date:  2010-11-24       Impact factor: 3.412

2.  Application of serum anti-Müllerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment.

Authors:  Hyun Ha Seok; Haengseok Song; Sang Woo Lyu; You Shin Kim; Dong Ryul Lee; Woo Sik Lee; Tae Ki Yoon
Journal:  Clin Exp Reprod Med       Date:  2016-06-23

3.  Ovarian hyperstimulation syndrome and prophylactic human embryo cryopreservation: analysis of reproductive outcome following thawed embryo transfer.

Authors:  Eric Scott Sills; Laura J McLoughlin; Marc G Genton; David J Walsh; Graham D Coull; Anthony P H Walsh
Journal:  J Ovarian Res       Date:  2008-11-06       Impact factor: 4.234

4.  Reproductive outcome following thawed embryo transfer in management of ovarian hyperstimulation syndrome.

Authors:  Forouzan Absalan; Alireza Ghannadi; Marjaneh Kazerooni
Journal:  J Reprod Infertil       Date:  2013-07

5.  Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome.

Authors:  V N A Ho; T D Pham; A H Le; T M Ho; L N Vuong
Journal:  J Ovarian Res       Date:  2018-08-27       Impact factor: 4.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.